Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2013
Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinomaHeidi Godoy, Paulette Mhawech-Fauceglia, Amy Beck, et al.
Proteomics. Clinical Applications|June 19, 2010
Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancerBiaoyang Lin, James T White, Jian Wu, et al.
Annals of Diagnostic Pathology|July 23, 2011
Clinically aggressive primary solid pseudopapillary tumor of the ovary in a 45-year-old womanSusanna Syriac, Joshua Kesterson, Iyare Izevbaye, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 30, 2008
Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved?Paulette Mhawech-Fauceglia, Kunle Odunsi, Daniel Dim, et al.
Gynecologic Oncology|October 11, 2005
Rhabdomyosarcoma of the cervix in sisters with review of the literatureJeannine A Villella, Paul N Bogner, Sheila N Jani-Sait, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferationFeng Qian, Jianqun Liao, Jeannine Villella, et al.
Cancer Immunity|February 8, 2013
Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patientsPaulette Mhawech-Fauceglia, Dan Wang, Liaquat Ali, et al.
Gynecologic Oncology|October 9, 2009
Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevancePaulette Mhawech-Fauceglia, Francois R Herrmann, Heidi Wagner, et al.
Gynecologic Oncology|June 19, 2012
Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinomaPaulette Mhawech-Fauceglia, Dan Wang, Damanzoopinder Samrao, et al.
Pageof 11